These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22452415)

  • 61. Circumcision related to urinary tract infections, sexually transmitted infections, human immunodeficiency virus infections, and penile and cervical cancer.
    Hayashi Y; Kohri K
    Int J Urol; 2013 Aug; 20(8):769-75. PubMed ID: 23573952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation.
    Smith DK; Taylor A; Kilmarx PH; Sullivan P; Warner L; Kamb M; Bock N; Kohmescher B; Mastro TD
    Public Health Rep; 2010; 125 Suppl 1(Suppl 1):72-82. PubMed ID: 20408390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acceptability of male circumcision for prevention of HIV infection in Zambia.
    Lukobo MD; Bailey RC
    AIDS Care; 2007 Apr; 19(4):471-7. PubMed ID: 17453585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 'snip' in time: what is the best age to circumcise?
    Morris BJ; Waskett JH; Banerjee J; Wamai RG; Tobian AA; Gray RH; Bailis SA; Bailey RC; Klausner JD; Willcourt RJ; Halperin DT; Wiswell TE; Mindel A
    BMC Pediatr; 2012 Feb; 12():20. PubMed ID: 22373281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modeling the population-level effects of male circumcision as an HIV-preventive measure: a gendered perspective.
    Dushoff J; Patocs A; Shi CF
    PLoS One; 2011; 6(12):e28608. PubMed ID: 22205956
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections.
    Matoga M; Hosseinipour MC; Jewett S; Hoffman IF; Chasela C
    Curr Opin Infect Dis; 2021 Feb; 34(1):50-55. PubMed ID: 33315750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Why circumcision is a biomedical imperative for the 21(st) century.
    Morris BJ
    Bioessays; 2007 Nov; 29(11):1147-58. PubMed ID: 17935209
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pros and cons of circumcision: an evidence-based overview.
    Friedman B; Khoury J; Petersiel N; Yahalomi T; Paul M; Neuberger A
    Clin Microbiol Infect; 2016 Sep; 22(9):768-774. PubMed ID: 27497811
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Longer-Term Follow-Up of Kenyan Men Circumcised Using the ShangRing Device.
    Feldblum PJ; Okech J; Ochieng R; Hart C; Kiyuka G; Lai JJ; Veena V
    PLoS One; 2015; 10(9):e0137510. PubMed ID: 26367141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Male circumcision and Sexually transmitted Infections - An update.
    Mehta KS; Marfatia YS; Jain AP; Shah DJ; Baxi DS
    Indian J Sex Transm Dis AIDS; 2021; 42(1):1-6. PubMed ID: 34765930
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Male circumcision for prevention of heterosexual acquisition of HIV in men.
    Siegfried N; Muller M; Deeks JJ; Volmink J
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003362. PubMed ID: 19370585
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 'It brought joy in my home as in the area of my wife.' How recently circumcised adult men ascribe value to and make sense of male circumcision.
    Lundsby K; Dræbel T; Wolf Meyrowitsch D
    Glob Public Health; 2012; 7(4):352-66. PubMed ID: 22087766
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda.
    Kibira SP; Sandøy IF; Daniel M; Atuyambe LM; Makumbi FE
    BMC Public Health; 2016 Jan; 16():7. PubMed ID: 26727935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Attitudes towards male circumcision among attendees at a sexually transmitted infection clinic in Kingston, Jamaica.
    Figueroa JP; Cooper CJ
    West Indian Med J; 2010 Jul; 59(4):351-5. PubMed ID: 21355507
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Male circumcision in the general population of Kisumu, Kenya: beliefs about protection, risk behaviors, HIV, and STIs.
    Westercamp M; Bailey RC; Bukusi EA; Montandon M; Kwena Z; Cohen CR
    PLoS One; 2010 Dec; 5(12):e15552. PubMed ID: 21179493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of the protective effect of male circumcision from HIV infection and sexually transmitted diseases: evidence from 18 demographic and health surveys in sub-Saharan Africa.
    Gebremedhin S
    Afr J Reprod Health; 2010 Jun; 14(2):105-13. PubMed ID: 21243923
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Understanding the socio-economic and sexual behavioural correlates of male circumcision across eleven voluntary medical male circumcision priority countries in southeastern Africa.
    Lau FK; Jayakumar S; Sgaier SK
    BMC Public Health; 2015 Aug; 15():813. PubMed ID: 26297202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Male circumcision: assessment of health benefits and risks.
    Moses S; Bailey RC; Ronald AR
    Sex Transm Infect; 1998 Oct; 74(5):368-73. PubMed ID: 10195035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Male circumcision as a measure to control HIV infection and other sexually transmitted diseases.
    Quigley MA; Weiss HA; Hayes RJ
    Curr Opin Infect Dis; 2001 Feb; 14(1):71-5. PubMed ID: 11979118
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.